Frontiers in medicine · 2026
The efficacy of acupuncture and related treatments on chronic pelvic inflammatory disease: a network meta-analysis.
СтатьяСистематический обзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zheng Yitong, He Jintao, Zheng Yijun, Ni Dongyi, Wang Yong
Аннотация
OBJECTIVE: To compare the efficacy of different acupuncture and related therapies for chronic pelvic inflammatory disease (CPID) and their effects on inflammatory factors via Network Meta-Analysis.
METHODS: Eight databases were systematically searched (up to April 20, 2025) for randomized controlled trials (RCTs) of acupuncture-related therapies for CPID. Eighty-four RCTs involving 8,147 patients were included. Study quality was assessed using the Cochrane risk-of-bias tool, and data were analyzed with R software.
RESULTS: AI interventions showed higher total effectiveness than conventional treatment. SUCRA rankings for total effectiveness: moxibustion combined with warm needle (89.1%), acupoint application therapy combined with ultrasound drug penetration (88.0%), and acupuncture combined with cupping (86.8%) ranked highest, while conventional treatment was the lowest (0.2%). For inflammatory factors: acupuncture showed the best improvement in IL-2 (61.6%); acupoint injection was optimal for TNF-α regulation (95.8%); moxibustion combined with acupuncture best modulated IL-6 (92.6%); and acupoint injection was best for CRP regulation (99.4%).
CONCLUSION: Acupuncture and related therapies are effective for CPID, with differences in regulating specific inflammatory factors, providing an evidence-based foundation. However, limitations like publication bias exist, warranting validation by high-quality studies.
SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/, identifier CRD420250655000.
METHODS: Eight databases were systematically searched (up to April 20, 2025) for randomized controlled trials (RCTs) of acupuncture-related therapies for CPID. Eighty-four RCTs involving 8,147 patients were included. Study quality was assessed using the Cochrane risk-of-bias tool, and data were analyzed with R software.
RESULTS: AI interventions showed higher total effectiveness than conventional treatment. SUCRA rankings for total effectiveness: moxibustion combined with warm needle (89.1%), acupoint application therapy combined with ultrasound drug penetration (88.0%), and acupuncture combined with cupping (86.8%) ranked highest, while conventional treatment was the lowest (0.2%). For inflammatory factors: acupuncture showed the best improvement in IL-2 (61.6%); acupoint injection was optimal for TNF-α regulation (95.8%); moxibustion combined with acupuncture best modulated IL-6 (92.6%); and acupoint injection was best for CRP regulation (99.4%).
CONCLUSION: Acupuncture and related therapies are effective for CPID, with differences in regulating specific inflammatory factors, providing an evidence-based foundation. However, limitations like publication bias exist, warranting validation by high-quality studies.
SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/, identifier CRD420250655000.